← Back
Data updated: Mar 10, 2026
PRECISION DOSE
Infectious DiseaseCardiovascular
PRECISION DOSE is a generic drug manufacturer focused on Infectious Disease, Cardiovascular.
1970
Since
5
Drugs
-
Trials
146
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
DOXYCYCLINE HYCLATE 2025-12-09
DOXYCYCLINE HYCLATE 2025-11-19
FOSFOMYCIN TROMETHAMINE 2025-11-14
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 67%
2 drugs
Cardiovascular 33%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 1970-11-21
- Latest
- 2025-06-03
- Applications
- 5
FDA Sponsor Names
PRECISION DOSEPRECISION DOSE INC